Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366427238> ?p ?o ?g. }
- W4366427238 abstract "Introduction We investigated whether prior SARS-CoV-2-specific IFN-γ and antibody responses in Ugandan COVID-19 pre-pandemic specimens aligned to this population's low disease severity. Methods We used nucleoprotein (N), spike (S), NTD, RBD, envelope, membrane, SD1/2-directed IFN-γ ELISpots, and an S- and N-IgG antibody ELISA to screen for SARS-CoV-2-specific cross-reactivity. Results HCoV-OC43-, HCoV-229E-, and SARS-CoV-2-specific IFN-γ occurred in 23, 15, and 17 of 104 specimens, respectively. Cross-reactive IgG was more common against the nucleoprotein (7/110, 15.5%; p = 0.0016, Fishers' Exact) than the spike (3/110, 2.72%). Specimens lacking anti-HuCoV antibodies had higher rates of pre-epidemic SARS-CoV-2-specific IFN-γ cross-reactivity (p-value = 0.00001, Fishers’ exact test), suggesting that exposure to additional factors not examined here might play a role. SARS-CoV-2-specific cross-reactive antibodies were significantly less common in HIV-positive specimens (p=0.017; Fishers' Exact test). Correlations between SARS-CoV-2- and HuCoV-specific IFN-γ responses were consistently weak in both HIV negative and positive specimens. Discussion These findings support the existence of pre-epidemic SARS-CoV-2-specific cellular and humoral cross-reactivity in this population. The data do not establish that these virus-specific IFN-γ and antibody responses are entirely specific to SARS-CoV-2. Inability of the antibodies to neutralise SARS-CoV-2 implies that prior exposure did not result in immunity. Correlations between SARS-CoV-2 and HuCoV-specific responses were consistently weak, suggesting that additional variables likely contributed to the pre-epidemic cross-reactivity patterns. The data suggests that surveillance efforts based on the nucleoprotein might overestimate the exposure to SARS-CoV-2 compared to inclusion of additional targets, like the spike protein. This study, while limited in scope, suggests that HIV-positive people are less likely than HIV-negative people to produce protective antibodies against SARS-CoV-2." @default.
- W4366427238 created "2023-04-21" @default.
- W4366427238 creator A5002865552 @default.
- W4366427238 creator A5006278831 @default.
- W4366427238 creator A5012815209 @default.
- W4366427238 creator A5016946329 @default.
- W4366427238 creator A5016998395 @default.
- W4366427238 creator A5023879855 @default.
- W4366427238 creator A5036257484 @default.
- W4366427238 creator A5044252717 @default.
- W4366427238 creator A5047905599 @default.
- W4366427238 creator A5053410104 @default.
- W4366427238 creator A5063674178 @default.
- W4366427238 creator A5067215044 @default.
- W4366427238 creator A5067630978 @default.
- W4366427238 creator A5075278910 @default.
- W4366427238 creator A5080642902 @default.
- W4366427238 creator A5087681201 @default.
- W4366427238 creator A5087752455 @default.
- W4366427238 date "2023-04-19" @default.
- W4366427238 modified "2023-10-13" @default.
- W4366427238 title "Pre-pandemic SARS-CoV-2-specific IFN-γ and antibody responses were low in Ugandan samples and significantly reduced in HIV-positive specimens" @default.
- W4366427238 cites W3047159181 @default.
- W4366427238 cites W3086701973 @default.
- W4366427238 cites W3095956988 @default.
- W4366427238 cites W3099989333 @default.
- W4366427238 cites W3113142876 @default.
- W4366427238 cites W3121008609 @default.
- W4366427238 cites W3134591945 @default.
- W4366427238 cites W3135345077 @default.
- W4366427238 cites W3138261380 @default.
- W4366427238 cites W3139475524 @default.
- W4366427238 cites W3160252417 @default.
- W4366427238 cites W3167718210 @default.
- W4366427238 cites W3183479225 @default.
- W4366427238 cites W3186809114 @default.
- W4366427238 cites W3199047933 @default.
- W4366427238 cites W4200460092 @default.
- W4366427238 cites W4205218806 @default.
- W4366427238 cites W4210935544 @default.
- W4366427238 cites W4220902888 @default.
- W4366427238 cites W4220930735 @default.
- W4366427238 cites W4220944349 @default.
- W4366427238 cites W4223893458 @default.
- W4366427238 cites W4226071034 @default.
- W4366427238 cites W4282030676 @default.
- W4366427238 cites W4285350473 @default.
- W4366427238 cites W4288429575 @default.
- W4366427238 cites W4293475796 @default.
- W4366427238 cites W4308580142 @default.
- W4366427238 cites W4327933560 @default.
- W4366427238 doi "https://doi.org/10.3389/fimmu.2023.1148877" @default.
- W4366427238 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37153598" @default.
- W4366427238 hasPublicationYear "2023" @default.
- W4366427238 type Work @default.
- W4366427238 citedByCount "1" @default.
- W4366427238 countsByYear W43664272382023 @default.
- W4366427238 crossrefType "journal-article" @default.
- W4366427238 hasAuthorship W4366427238A5002865552 @default.
- W4366427238 hasAuthorship W4366427238A5006278831 @default.
- W4366427238 hasAuthorship W4366427238A5012815209 @default.
- W4366427238 hasAuthorship W4366427238A5016946329 @default.
- W4366427238 hasAuthorship W4366427238A5016998395 @default.
- W4366427238 hasAuthorship W4366427238A5023879855 @default.
- W4366427238 hasAuthorship W4366427238A5036257484 @default.
- W4366427238 hasAuthorship W4366427238A5044252717 @default.
- W4366427238 hasAuthorship W4366427238A5047905599 @default.
- W4366427238 hasAuthorship W4366427238A5053410104 @default.
- W4366427238 hasAuthorship W4366427238A5063674178 @default.
- W4366427238 hasAuthorship W4366427238A5067215044 @default.
- W4366427238 hasAuthorship W4366427238A5067630978 @default.
- W4366427238 hasAuthorship W4366427238A5075278910 @default.
- W4366427238 hasAuthorship W4366427238A5080642902 @default.
- W4366427238 hasAuthorship W4366427238A5087681201 @default.
- W4366427238 hasAuthorship W4366427238A5087752455 @default.
- W4366427238 hasBestOaLocation W43664272381 @default.
- W4366427238 hasConcept C126322002 @default.
- W4366427238 hasConcept C159047783 @default.
- W4366427238 hasConcept C159654299 @default.
- W4366427238 hasConcept C203014093 @default.
- W4366427238 hasConcept C2522874641 @default.
- W4366427238 hasConcept C2779134260 @default.
- W4366427238 hasConcept C2779142602 @default.
- W4366427238 hasConcept C2779341262 @default.
- W4366427238 hasConcept C2908647359 @default.
- W4366427238 hasConcept C3008058167 @default.
- W4366427238 hasConcept C3020064264 @default.
- W4366427238 hasConcept C524204448 @default.
- W4366427238 hasConcept C60325843 @default.
- W4366427238 hasConcept C71924100 @default.
- W4366427238 hasConcept C86803240 @default.
- W4366427238 hasConcept C8891405 @default.
- W4366427238 hasConcept C89623803 @default.
- W4366427238 hasConcept C99454951 @default.
- W4366427238 hasConceptScore W4366427238C126322002 @default.
- W4366427238 hasConceptScore W4366427238C159047783 @default.
- W4366427238 hasConceptScore W4366427238C159654299 @default.
- W4366427238 hasConceptScore W4366427238C203014093 @default.
- W4366427238 hasConceptScore W4366427238C2522874641 @default.
- W4366427238 hasConceptScore W4366427238C2779134260 @default.